| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000229278.1 |
Temsirolimus |
Bladder urothelial carcinoma |
0.003244323 |
Resistant |
| ENSG00000229278.1 |
Temsirolimus |
Chronic Lymphocytic Leukemia |
0.032158271 |
Resistant |
| ENSG00000229278.1 |
Temsirolimus |
Skin cutaneous melanoma |
0.027785564 |
Resistant |
